Royal Bank of Canada
AVNS

Royal Bank of Canada’s Avanos Medical AVNS Stock Holding History

Royal Bank of Canada’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$43K Sell
3,056
-39,824
-93% -$537K ﹤0.01% 5559
2025
Q4 		$481K Sell
42,880
-147,079
-77% -$1.68M ﹤0.01% 4194
2025
Q3 		$2.2M Buy
189,959
+28,811
+18% +$337K ﹤0.01% 3331
2025
Q2 		$1.97M Buy
161,148
+91,135
+130% +$1.15M ﹤0.01% 3319
2025
Q1 		$1M Sell
70,013
-465,194
-87% -$7.26M ﹤0.01% 3482
2024
Q4 		$8.52M Sell
535,207
-45,347
-8% -$897K ﹤0.01% 1906
2024
Q3 		$13.9M Sell
580,554
-7,323
-1% -$167K ﹤0.01% 1570
2024
Q2 		$11.7M Sell
587,877
-12,303
-2% -$240K ﹤0.01% 1577
2024
Q1 		$12M Sell
600,180
-37,786
-6% -$730K ﹤0.01% 1571
2023
Q4 		$14.3M Buy
637,966
+16,363
+3% +$338K ﹤0.01% 1480
2023
Q3 		$12.6M Sell
621,603
-9,206
-1% -$209K ﹤0.01% 1423
2023
Q2 		$16.1M Buy
630,809
+11,762
+2% +$310K ﹤0.01% 1281
2023
Q1 		$18.4M Buy
619,047
+98,260
+19% +$2.85M 0.01% 1185
2022
Q4 		$14.1M Buy
520,787
+10,914
+2% +$267K ﹤0.01% 1380
2022
Q3 		$11.1M Sell
509,873
-9,668
-2% -$253K ﹤0.01% 1455
2022
Q2 		$14.2M Sell
519,541
-3,100
-0.6% -$89.1K ﹤0.01% 1321
2022
Q1 		$17.5M Buy
522,641
+3,044
+0.6% +$98K ﹤0.01% 1313
2021
Q4 		$18M Sell
519,597
-842
-0.2% -$27.2K ﹤0.01% 1458
2021
Q3 		$16.2M Buy
520,439
+593
+0.1% +$20.1K ﹤0.01% 1492
2021
Q2 		$18.9M Sell
519,846
-18,529
-3% -$766K 0.01% 1387
2021
Q1 		$23.5M Sell
538,375
-40,752
-7% -$1.91M 0.01% 1160
2020
Q4 		$26.6M Sell
579,127
-13,533
-2% -$563K 0.01% 1068
2020
Q3 		$19.7M Buy
592,660
+35,724
+6% +$1.14M 0.01% 1082
2020
Q2 		$16.4M Sell
556,936
-2,010
-0.4% -$58.2K 0.01% 1154
2020
Q1 		$15.1M Buy
558,946
+131,178
+31% +$3.92M 0.01% 1067
2019
Q4 		$14.4M Buy
427,768
+103,126
+32% +$3.73M 0.01% 1363
2019
Q3 		$12.2M Buy
324,642
+315,588
+3,486% +$12M ﹤0.01% 1418
2019
Q2 		$395K Buy
9,054
+1,971
+28% +$84.3K ﹤0.01% 4004
2019
Q1 		$302K Buy
7,083
+1,306
+23% +$58.5K ﹤0.01% 4088
2018
Q4 		$259K Sell
5,777
-18,259
-76% -$957K ﹤0.01% 4182
2018
Q3 		$1.65M Buy
24,036
+18,780
+357% +$1.21M ﹤0.01% 2989
2018
Q2 		$301K Buy
5,256
+707
+16% +$37.4K ﹤0.01% 4162
2018
Q1 		$208K Sell
4,549
-13,048
-74% -$619K ﹤0.01% 4299
2017
Q4 		$813K Sell
17,597
-4,753
-21% -$218K ﹤0.01% 3392
2017
Q3 		$1.01M Buy
22,350
+4,980
+29% +$213K ﹤0.01% 3209
2017
Q2 		$681K Sell
17,370
-4,727
-21% -$179K ﹤0.01% 3412
2017
Q1 		$841K Sell
22,097
-4,541
-17% -$177K ﹤0.01% 3206
2016
Q4 		$984K Buy
26,638
+5,419
+26% +$194K ﹤0.01% 3171
2016
Q3 		$735K Buy
21,219
+9,728
+85% +$341K ﹤0.01% 3390
2016
Q2 		$373K Sell
11,491
-5,801
-34% -$178K ﹤0.01% 3940
2016
Q1 		$496K Sell
17,292
-1,917
-10% -$51.1K ﹤0.01% 3650
2015
Q4 		$641K Buy
19,209
+3,079
+19% +$95.7K ﹤0.01% 3526
2015
Q3 		$460K Sell
16,130
-10,328
-39% -$360K ﹤0.01% 3594
2015
Q2 		$1.07M Sell
26,458
-69,177
-72% -$3.1M ﹤0.01% 2847
2015
Q1 		$4.71M Buy
95,635
+65,832
+221% +$3.05M ﹤0.01% 1644
2014
Q4 		$1.36M Buy
+29,803
New +$1.17M ﹤0.01% 2655

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Royal Bank of Canada's AVNS Position: Q1 2026 in Review

Royal Bank of Canada reduced its Avanos Medical (AVNS) stake by 93% in Q1 2026, selling an estimated $537K and leaving 3,056 shares worth $43K. The position accounts for ﹤0.01% of the portfolio, ranked #5559.

Royal Bank of Canada first reported a position in AVNS in Q4 2014 and has held it in 46 quarters since. The position peaked at $26.6M in Q4 2020. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

  • Royal Bank of Canada held 3,056 shares of Avanos Medical worth $43K as of Q1 2026.
  • Royal Bank of Canada sold 39,824 Avanos Medical shares in Q1 2026, an estimated $537K.
  • Avanos Medical made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #5559 holding.
  • Royal Bank of Canada first reported a position in Avanos Medical in Q4 2014 and has held it in 46 quarters since.
  • Royal Bank of Canada's Avanos Medical position peaked at $26.6M in Q4 2020.
  • 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.